Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be on your first protease inhibitor (PI) containing regimen, and the regimen must consist of a PI +/- ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N\[t\]RTIs).
Have a plasma HIV-1 RNA level (viral load) at screening of less than 400 copies/mL, for at least 3 months prior to Screening and at Screening while on your current regimen of a PI +/- ritonavir + 2 N(t)RTIs.
Females must not be pregnant or breastfeeding or plan to become pregnant during the study.
Females of child-bearing potential must agree to use one of the approved methods of birth control.
You may not be if
Not able to follow the medication schedules and attend the study visits for the entire length of the study.
Have any other illnesses, laboratory test results, medication use, allergies, or medical conditions that would make it unsafe for the subject to participate in this study.
Currently be enrolled in any other research studies that could affect the subject''''s HIV-1 RNA levels.
Clareo Health | Fosamprenavir Versus Other Protease Inhibitors
